This E-learning courses are organized for regulators only.
	Registration is necessary in advance.
Class: Clinical trials
- Regulations for Clinical trials
 - First-in-Human studies
 - MRCTs and ICH E17 guideline April 25, 2025 Updated
 - Example of Bridging Strategy
 - Points of attention for consultation about MRCT from PMDA’s experience
 
Class: GCP
- How to Conduct GCP inspection in Japan
 
Class: Review
- Review Process of New Drugs
 - Application Dossier
 - Expedited regulatory pathways
 - Points to Consider in the Evaluation of New Drug
 - Review of Orphan Drugs
 - PMDA’s Experiences to Review MRCT Results
 - Review of Chemistry Manufacturing and Control (CMC)
 - Review of CMC for Biotechnology-Derived Products April 25, 2025 newly posted
 - Overview of Drug Master File System in Japan April 25, 2025 newly posted
 - Japanese Pharmacopoeia (JP)
 
Class: Generic Drugs
- Review of Generic drugs
 - Bioequivalence Study
 
Class: GMP
- GMP Regulatory system in Japan and GMP Certificate
 - PMDA's international activities as a GMP inspectorate
 - Risk assessment of manufacturing site
 
	Class: RMP
- Risk Management Plan (RMP)
 - Pharmacovigilance Activities April 25, 2025 Updated
 - Risk Minimization Activity
 - Pharmacovigilance activities utilizing Real-World Data in PMDA
 
Class: Labeling
- Overview of Labeling Information (Package Insert)
 - E-Labeling system in Japan
 
Class: Risk Communication
- Risk Communication April 25, 2025 Updated
 
	Class: Post approval clinical study surveys
- Basics of Epidemiology
 
	 


